Star Therapeutics VWD Webinar
Interested in learning about a new VWD Treatment? Star Therapeutics’ is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039.
If you or someone in your family has any type of VWD, please join us for an engaging session as Dr. Laura Guido, Head of Medical Affairs at Star Therapeutics, shares how VGA039 works, its clinical development path, and early trial results. Dr. Guido will also discuss our VIVID Clinical Trials and how to explore eligibility and participate.
Zoom Community Meeting for Nevadans
Tuesday, February 17th, 6pm – 7:15pm PST
